U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07463872) titled 'Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data' on Dec. 09, 2025.
Brief Summary: The primary objective is to construct a multimodal AI model (Cyst-AI) based on EUS images and clinical data such as imaging features(CT or MRI) and laboratory tests to assist endoscopists in the diagnosis of pancreatic cystic lesions(PCLs), mainly differentiating mucinous from non-mucinous lesions.
The secondary objective is to evaluate the model's effectiveness in risk stratification and clinical management for patients with PCLs.
Study Start Date: Jan. 01, 2025
Study Type: OBSERVATIONAL
Cond...